Neurocrine Biosciences
NBIX
#1461
Rank
S$15.95 B
Marketcap
$160.02
Share price
1.03%
Change (1 day)
-11.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$1.52 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are S$1.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$1.34 B51.95%
2022-12-31S$0.88 B-6.17%
2021-12-31S$0.94 B17.3%
2020-12-31S$0.80 B-10.76%
2019-12-31S$0.90 B28.87%
2018-12-31S$0.69 B17.49%
2017-12-31S$0.59 B719.89%
2016-12-31S$72.66 M2.07%
2015-12-31S$71.19 M56.93%
2014-12-31S$45.36 M4.5%
2013-12-31S$43.41 M-14.68%
2012-12-31S$50.88 M-49.81%
2011-12-31S$0.10 B-37.07%
2010-12-31S$0.16 B71.64%
2009-12-31S$93.87 M-19.37%
2008-12-31S$0.11 B-48.78%
2007-12-31S$0.22 B97.75%
2006-12-31S$0.11 B-25.78%
2005-12-31S$0.15 B-24.29%
2004-12-31S$0.20 B-26.51%
2003-12-31S$0.27 B279.38%
2002-12-31S$73.37 M10.23%
2001-12-31S$66.56 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.09 B-27.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.62 B 597.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$14.41 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
S$86.86 B 5,608.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$177.64 B 11,573.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$171.07 B 11,141.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.15 B-24.13%๐Ÿ‡บ๐Ÿ‡ธ USA
S$59.06 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA